Udvalget for Farmaceutiske Specialiteter (CPMP) satte spørgsmålstegn ved medtagelsen af Fredrickson- klassifikationen i indikationsteksten, delvis fordi denne klassifikation er ved at være forældet.
The inclusion of the Fredrickson classification in the wording of the indication was questioned by the CPMP, partly due to the fact that this classification is becoming obsolete.